✦ LIBER ✦

Bronchoprotective and bronchodilator effects of single doses of (S)-salbutamol, (R)-salbutamol and racemic salbutamol in patients with bronchial asthma

✍ Scribed by C. M. Ramsay; J. Cowan; E. Flannery; C. McLachlan; D. R. Taylor

Publisher: Springer
Year: 1999
Tongue: English
Weight: 125 KB
Volume: 55
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s002280050640

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, efficacy and adverse e

Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in Patients with asthma

✍ B. J. Lipworth; R. A. Clark; D. P. Dhillon; T. A. Moreland; A. D. Struthers; G. 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 663 KB

Single dose and steady-state pharmacokin

Single dose and steady-state pharmacokinetics of 4 mg and 8 mg oral salbutamol controlled-release in patients with bronchial asthma

✍ B. J. Lipworth; R. A. Clark; D. P. Dhillon; M. K. Charter; J. B. D. Palmer; D. G 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 450 KB

A comparison of the bronchodilating effe

A comparison of the bronchodilating effects of salmeterol, salbutamol and Ipratropium bromide in patients with chronic obstructive pulmonary disease

✍ M.G. Matera; M. Cazzola; A. Vinciguerra; F. Di Perna; F. Calderaro; M. Caputi; F 📂 Article 📅 1995 🏛 Elsevier 🌐 English ⚖ 587 KB

Bronchodilator efficacy of salbutamol (200 pg), salmeterol (50 pg) and ipratropium bromide (40 pg) aerosols has been compared in 16 patients with stable chronic obstructive pulmonary disease (COPD) using a double-blind placebo controlled cross-over design. When absolute changes in FEV~ were used as

Comparison of the efficacy and systemic

Comparison of the efficacy and systemic effects of 4 mg and 8 mg formulations of salbutamol controlled release in patients with asthma

✍ B. J. Lipworth; R. A. Clark; D. P. Dhillon; J. B. D. Palmer; D. G. McDevitt 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 576 KB

The Lack of Bronchodilator Effect and th

The Lack of Bronchodilator Effect and the Short-term Safety of Cumulative Single Doses of an Inhaled Potassium Channel Opener (Bimakalim) in Adult Patients with Mild to Moderate Bronchial Asthma

✍ P. Faurschou; K.L. Mikkelsen; I. Steffensen; B. Franke 📂 Article 📅 1994 🏛 Elsevier 🌐 English ⚖ 230 KB

SUMMARY: The aim of this study was to assess the bronchodilator effect and short-term safety of cumulative single doses of inhaled bimakalim (E Merck, Darmstadt), a potassium channel opener, compared to placebo in 12 adult patients with chronic, mild to moderate, non-allergic bronchial asthma. The s